Brellier Ludovic
Known title: EVP, Bioscience & MedtechCIK: 0002132959
Associated companies
Transaction History
| AVTR | ▲ Buy | Grant | 146,566 | $0 | 5/1/2026 | View on chart |
| AVTR | ▲ Buy | Grant | 146,566 | $0 | 5/1/2026 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Avantor to Report Q3 2026 Earnings on October 28
Avantor has scheduled its third-quarter 2026 earnings release for Wednesday, October 28, 2026. Recent coverage notes that the company led peer groups in research tools and consumables during the second quarter. The stock is currently trading near the lower end of its 52-week range, with analysts maintaining a wide target price spread.
Avantor to Report Q3 2026 Earnings on October 28. Avantor has scheduled its third-quarter 2026 earnings release for Wednesday, October 28, 2026. Recent coverage notes that the company led peer groups in research tools and consumables during the second quarter. The stock is currently trading near the lower end of its 52-week range, with analysts maintaining a wide target price spread.